文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

痴呆行为和心理症状管理的最佳实践

Best practice in the management of behavioural and psychological symptoms of dementia.

作者信息

Tible Olivier Pierre, Riese Florian, Savaskan Egemen, von Gunten Armin

机构信息

Department of Psychiatry, Service Universitaire de Psychiatrie de l'Age Avancé (SUPAA), Lausanne University Hospital, CH-1008 Prilly, Switzerland.

Department of Geriatric Psychiatry, University Hospital of Psychiatry, Zurich, Switzerland University Research Priority Programme 'Dynamics of Healthy Aging', University of Zurich, Zurich, Switzerland.

出版信息

Ther Adv Neurol Disord. 2017 Aug;10(8):297-309. doi: 10.1177/1756285617712979. Epub 2017 Jun 19.


DOI:10.1177/1756285617712979
PMID:28781611
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5518961/
Abstract

Behavioural and psychological symptoms of dementia (BPSD) occur in most patients with dementia. They cause great suffering in patients and caregivers, sometimes more so than the cognitive and functional decline inherent to dementia. The clinical features of BPSD include a wide variety of affective, psychotic and behavioural symptoms and signs. The causes and risk factors for BPSD are multiple and include biological, psychological and environmental variables. Frequently, their combination, rather than any specific factor, explains the occurrence of BPSD in an individual patient. Thus, a sound etiopathogenetic investigation including the patient and the family or care team is essential. The aim is to develop an individualized treatment plan using a therapeutic decision tree modified by the individual and environmental risk profile. Still, treatment may be difficult and challenging. Clinical empiricism often steps in where evidence from controlled studies is lacking. Psychosocial treatment approaches are pivotal for successful treatment of BPSD. Often a combination of different non-pharmacological approaches precedes drug treatment (most of which is off-label). Regular assessments of the treatment plan and any prescriptions must be carried out to detect signs of relapse and to stop any medicines that may have become inappropriate. Even with optimal management, BPSD will not disappear completely in some cases and will remain challenging for all involved parties. This article is a narrative review based closely on the interprofessional Swiss recommendations for the treatment of BPSD. To establish the recommendations, a thorough research of the literature has been carried out. Evidence-based data were provided through searches of Medline, Embase, ISI and Cochrane-Database research. Evidence categories of the World Federation of Biological Societies were used. Additionally, the clinical experience of Swiss medical experts was considered.

摘要

大多数痴呆患者会出现痴呆的行为和心理症状(BPSD)。这些症状给患者及其照料者带来巨大痛苦,有时甚至比痴呆本身固有的认知和功能衰退更甚。BPSD的临床特征包括各种各样的情感、精神病性及行为症状和体征。BPSD的病因和风险因素是多方面的,包括生物学、心理学和环境变量。通常,这些因素的综合作用而非任何特定因素,解释了个体患者中BPSD的发生情况。因此,对患者及其家庭或护理团队进行全面的病因学调查至关重要。目的是根据个体和环境风险状况调整治疗决策树,制定个性化的治疗方案。然而,治疗可能困难且具有挑战性。在缺乏对照研究证据时,临床经验主义常常发挥作用。心理社会治疗方法对于成功治疗BPSD至关重要。通常在药物治疗(大多为超说明书用药)之前,先采用不同非药物方法的联合治疗。必须定期评估治疗方案和任何处方,以发现复发迹象并停用可能已变得不合适的药物。即使进行了最佳管理,在某些情况下BPSD也不会完全消失,对所有相关方来说仍然是一个挑战。本文是一篇叙述性综述,紧密基于瑞士跨专业的BPSD治疗建议。为制定这些建议,已对文献进行了全面研究。通过检索Medline、Embase、ISI和Cochrane数据库研究提供了循证数据。采用了世界生物学会联合会的证据类别。此外,还考虑了瑞士医学专家的临床经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc1/5518961/030dcc90a98b/10.1177_1756285617712979-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc1/5518961/dc2b4dc528fb/10.1177_1756285617712979-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc1/5518961/030dcc90a98b/10.1177_1756285617712979-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc1/5518961/dc2b4dc528fb/10.1177_1756285617712979-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbc1/5518961/030dcc90a98b/10.1177_1756285617712979-fig2.jpg

相似文献

[1]
Best practice in the management of behavioural and psychological symptoms of dementia.

Ther Adv Neurol Disord. 2017-8

[2]
'Working away in that Grey Area…' A qualitative exploration of the challenges general practitioners experience when managing behavioural and psychological symptoms of dementia.

Age Ageing. 2018-3-1

[3]
[Premorbid personality as a risk factor in the appearance of psychological and behavioural symptoms of dementia: Systematic review].

Rev Esp Geriatr Gerontol. 2019

[4]
Management of the behavioral and psychological symptoms of dementia.

Clin Interv Aging. 2007

[5]
Expert opinion on the management of behavioural and psychological symptoms of dementia (BPSD) and investigation into prescribing practices in the UK.

Int J Geriatr Psychiatry. 2009-9

[6]

2008-6

[7]
The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations.

Psychogeriatrics. 2024-7

[8]
The Influence of Telemedicine Care on the Management of Behavioral and Psychological Symptoms in Dementia (BPSD) Risk Factors Induced or Exacerbated During the COVID-19 Pandemic.

Front Psychiatry. 2020-9-15

[9]
Management of Behavioral and Psychological Symptoms of Dementia.

Curr Psychiatry Rep. 2019-7-1

[10]
[Psychological and behavioural symptoms of dementia: prevention, diagnosis and treatment].

Rev Neurol. 2012-11-16

引用本文的文献

[1]
Exploring the Therapeutic Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) in Individuals With Alzheimer's Disease: A Comprehensive Narrative Review.

Cureus. 2025-5-27

[2]
The Use of Equine-Assisted Therapy in Patients With Aggression and Agitation Behaviors due to Moderate-to-Severe Dementia: A Case Series.

Case Rep Psychiatry. 2025-6-4

[3]
Implementation of the Cognitive Daisy (COG-D) for improving care planning and delivery for residents with dementia in care homes: results of a feasibility randomised controlled trial.

Pilot Feasibility Stud. 2025-5-10

[4]
Impact of potentially inappropriate psychotropic medicines on falls among older adults in 23 residential aged care facilities in Australia: a retrospective longitudinal cohort study.

BMJ Open. 2025-4-9

[5]
Aging Gut-Brain Interactions: Pro-Inflammatory Gut Bacteria Are Elevated in Fecal Samples from Individuals Living with Alzheimer's Dementia.

Geriatrics (Basel). 2025-3-7

[6]
Use of Virtual Reality to Improve Spatial Orientation in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.

Curr Alzheimer Res. 2024

[7]
Psychotropic Polypharmacy in Dementia: A Retrospective Analysis for People with Neuropsychiatric Symptoms Referred to an Australian Dementia Support Service.

Drugs Aging. 2025-2

[8]
Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review.

Clin Pharmacokinet. 2025-3

[9]
Longitudinal study of care needs and behavioural changes in people living with dementia using in-home assessment data.

Commun Med (Lond). 2025-1-10

[10]
The process of pain assessment in people with dementia living in nursing homes: a scoping review.

Palliat Care Soc Pract. 2025-1-6

本文引用的文献

[1]
Sleep, Cognitive impairment, and Alzheimer's disease: A Systematic Review and Meta-Analysis.

Sleep. 2017-1-1

[2]
Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series.

BMJ Open. 2017-3-16

[3]
Sleep-Wake Profile in Dementia with Lewy Bodies, Alzheimer's Disease, and Normal Aging.

J Alzheimers Dis. 2017

[4]
Metabotropic glutamate receptors and neurodegenerative diseases.

Pharmacol Res. 2017-1

[5]
Pharmacotherapies for sleep disturbances in dementia.

Cochrane Database Syst Rev. 2016-11-16

[6]
Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis.

Int Psychogeriatr. 2017-2

[7]
Brain Regions Involved in Arousal and Reward Processing are Associated with Apathy in Alzheimer's Disease and Frontotemporal Dementia.

J Alzheimers Dis. 2017

[8]
Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease.

J Neurol Sci. 2016-11-15

[9]
Childhood Trauma and COMT Genotype Interact to Increase Hippocampal Activation in Resilient Individuals.

Front Psychiatry. 2016-9-14

[10]
Cholinergic Changes in Aging and Alzheimer Disease: An [18F]-F-A-85380 Exploratory PET Study.

Alzheimer Dis Assoc Disord. 2017

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索